UNSPSC 42321801: Femoral knee components

In this classification, this commodity indicates a product used as a femoral knee component in a surgical procedure in a medical setting. US FDA regulates Femoral knee components under 21 CFR 888.3510 and under FDA product code KRO. Most nations, for tariff and trade purposes, schedule these products under HS 902129.

UNSPSC 42321801 Femoral knee components is a Commodity code, but state and local procurement activity under this code shows little recent relevance to the nominal product scope. The most recent posted opportunities tagged to this code span cooperative-purchasing vehicles for broad medical supplies, physical health products, outpatient building furniture, orthopedic hardware extraction systems, and law enforcement equipment — none of which directly address femoral knee implants or orthopedic knee components. The mismatch between the code's intended scope and the actual work being solicited suggests either inconsistent tagging by issuing bodies or that knee components are bundled within larger medical-supply or orthopedic-services aggregations rather than procured as standalone line items at the state and local level.

The recent opportunities span NASPO ValuePoint (a multi-state cooperative purchasing vehicle administered by South Dakota), Sourcewell (a Minnesota local government cooperative serving thousands of public entities across the United States and Canada), the State of California, and San Mateo Medical Center in California. Geographic spread includes South Dakota, Minnesota, California, and Washington, with national reach through cooperative-purchasing vehicles. Representative solicitations include NASPO ValuePoint RFP 1433 for master-agreement medical supplies (proposals due November 9, 2026), Sourcewell RFP 26RFP102026 for physical health products and related services (due October 20, 2026), and San Mateo Medical Center's orthopedic hardware removal and extraction system services RFP 666002526252 (due July 1, 2026, with local-business preference of 5 to 10 percent available). The data supports no recent standalone solicitations for femoral knee components specifically.